BioReference Laboratories
With the COVID-19 pandemic driving new investment and uptake of telemedicine, more providers are looking to offer their patients easy access to lab testing.
360Dx Index Maintains Steady Ascent, Increasing 3 Percent in August
Of the 29 companies in the index, 18 saw increases in their stock prices, while 11 saw declines.
BioReference Labs Acquires US Ariosa Lab NIPT Business From Roche
The business will complement BioReference's specialty health division GenPath, which offers a noninvasive prenatal screening test.
In Brief This Week: FIND, Sophia Genetics, Dante Labs, BioReference Laboratories, and More
News items for the in vitro diagnostics industry for the week of July 26, 2021.
Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent
The firm saw increases in SARS-CoV-2, clinical, and genomic testing and processed approximately 2.8 million COVID-19 PCR tests.
May 6, 2021
Apr 29, 2021
Apr 7, 2021
Jan 21, 2021
Oct 30, 2020